233 — Kennewick, Washington

233 is a clinical research site located in Kennewick, Washington, United States.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

233 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 233?

233 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 233 conducted?

233 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 233 accredited by Crixeo Health?

233 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 233?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.